Veradermics, Inc
MANE- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827635
In the last 90 days, Veradermics, Inc insiders filed 0 open-market purchases and 4 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $4.17B in total; superinvestors Viking Global Investors and Maverick Capital hold it.
Superinvestors holding MANE, Q2 2026
2 superinvestors report holding Veradermics, Inc on Form 13F, worth $289.1M in total. Weight is Veradermics, Inc's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | 0.5% | 1,561,494 | $192.0M | Reduced−7.6% |
| Maverick CapitalLee Ainslie | 0.9% | 789,980 | $97.1M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of MANE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
2 superinvestors holding at quarter end
- New
- Maverick Capital
- Reduced
- Viking Global Investors (−7.6%)
Q1 2026
1 superinvestor holding at quarter end